In vivo therapy of oncogenic viruses.
D000406:AKR murine leukemia virus / Q000302:isolation & purification; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology; D001001:Anura; D001358:Avian Sarcoma Viruses / Q000302:isolation & purification; D001688:Biological Products / Q000494:pharmacology; D002415:Cats; D002417:Cattle; D006224:Cricetinae; D004285:Dogs; D005622:Friend murine leukemia virus / Q000302:isolation & purification; D006168:Guinea Pigs; D000882:Haplorhini; D007112:Immunity, Maternally-Acquired; D007372:Interferons / Q000494:pharmacology; D051379:Mice; D008979:Moloney murine leukemia virus / Q000302:isolation & purification; D009369:Neoplasms / Q000188:drug therapy / Q000209:etiology / Q000276:immunology / Q000517:prevention & control* / Q000532:radiotherapy / Q000628:therapy; D009858:Oncogenic Viruses / Q000187:drug effects / Q000276:immunology; D011817:Rabbits; D051381:Rats; D011925:Rauscher Virus / Q000302:isolation & purification; D014612:Vaccines / Q000494:pharmacology; D014762:Viral Interference
D000970:Antineoplastic Agents; D001688:Biological Products; D014612:Vaccines; D007372:Interferons